Life Technologies Corporation (NASDAQ: LIFE) announced the creation of the Genomic Cancer Care Alliance to help people battling cancer gain access to treatment options found through analysis of their genomic information. Founding partners include Fox Chase Cancer Center, Scripps Genomic Medicine, and the Translational Genomics Research Institute (TGen).The [...]
Life Technologies said Friday it is applying its gene sequencing prowess to a challenging project: detecting genetic information about breast cancers that show no sign of obvious mutations linked with the disease. Source: General Cancer News Articles Provided by Cancer Compass
Genomic Health, Inc. announced worldwide commercial availability of its Oncotype DX colon cancer test, the first multigene expression test developed for the assessment of risk of recurrence in patients with stage II disease. The 12-gene advanced diagnostic test is clinically validated to predict individual recurrence risk in stage [...]
Genomic Health Announces Worldwide Availability of the Oncotype DX(R) Colon Cancer Test REDWOOD CITY, Calif., Jan. 21 /PRNewswire-FirstCall/ — Genomic Health, Inc. Read more on redOrbit